Cargando…
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer: A retrospective study
Upregulated delta-like protein 3 (DLL3) functions as a Notch ligand and has been a target for cancer therapy. The present study assessed DLL3 expression as a tumor marker for endometrial cancer. RNA-Seq expression data and clinicopathologic records from 545 patients with endometrial cancer were down...
Autores principales: | Wang, Juan, Zhang, Kaishuo, Liu, Zi, Wang, Tao, Shi, Fan, Zhang, Yingbing, Su, Jin, Jia, Yina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320086/ https://www.ncbi.nlm.nih.gov/pubmed/30572444 http://dx.doi.org/10.1097/MD.0000000000013442 |
Ejemplares similares
-
LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
por: Shi, Fan, et al.
Publicado: (2019) -
Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer
por: Yang, Hua, et al.
Publicado: (2020) -
Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR
por: Shi, Fan, et al.
Publicado: (2019) -
Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020) -
PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)